Type 2 & other diabetes

Cardiovascular outcomes associated with incident diabetes during statin therapy: a nationwide propensity-matched cohort study

Cardiovasc DiabetolPublished Retrospective cohort study

Authors' conclusion

Diabetes that develops during statin therapy was associated with a lower risk of MACE compared with initiating statins after diabetes diagnosis and was not linked to increased risk of MACE or all-cause mortality compared with remaining diabetes-free.

Study context

Population
Adults in the Korean National Health Insurance Service database, 2009–2020, primary and secondary care; Study 1: 4371 incident-diabetes statin users matched 1:1 by age, sex and LDL-C; Study 2: 4191 matched 1:1source population 1,500,959
Exposure
Incident T2D during statin therapy vs statin initiation after prior T2D (Study 1); vs statin users remaining diabetes-free (Study 2)
  • Incident T2DM on statin (Study 1)n = 4,371
  • Incident T2DM on statin (Study 2)n = 4,191
Outcome
Major adverse cardiovascular events (MACE): composite of MI and stroke
Methodological detailstwo cohort studies, nationwide, population-based, propensity score-matched 1:1
  • Two cohort studies
  • Nationwide
  • Population-based
  • Propensity score-matched 1:1

Main finding

As reported in the abstract

MACE
Adjusted hazard ratio (95% CI)P value
Incident diabetes on statinvs Statin after T2DMStudy 1
0.607(0.458–0.805)
P = 0.0005
Incident diabetes on statinvs Diabetes-free statin usersStudy 2
1.122(0.784–1.605)
P = 0.53

Observational data: associations, not effects.

Secondary outcomes

OutcomeaHR (95% CI)P value
Stroke (Study 1)Incident diabetes on statinvs Statin after T2DM0.504 (0.357–0.711)P < 0.001
All-cause mortality (Study 2)Incident diabetes on statinvs Diabetes-free statin users0.555 (0.290–1.063)P = 0.0758

Original publication

Cardiovascular outcomes associated with incident diabetes during statin therapy: a nationwide propensity-matched cohort study. Cardiovasc Diabetol. Published 24 December 2025. doi:10.1186/s12933-025-03003-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.